We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-10.38%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$22.2B
AUM Growth
-$4.5B
(-17%)
Cap. Flow
-$713M
Cap. Flow
% of AUM
-3.22%
Top 10 Holdings %
Top 10 Hldgs %
43.61%
Holding
509
New
64
Increased
149
Reduced
123
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$92.3M |
| 2 |
Unity
U
|
+$91.8M |
| 3 |
Shopify
SHOP
|
+$85.5M |
| 4 |
Synopsys
SNPS
|
+$83.6M |
| 5 |
Palo Alto Networks
PANW
|
+$79.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$180M |
| 2 |
Seagate
STX
|
+$129M |
| 3 |
PCGU
PG&E Corporation
PCGU
|
+$116M |
| 4 |
Amazon
AMZN
|
+$88.4M |
| 5 |
Aptiv
APTV
|
+$79.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.75% |
| 2 | Industrials | 22.4% |
| 3 | Healthcare | 16.04% |
| 4 | Financials | 12.03% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bristol-Myers Squibb
BMY
$130B
| $31.9M | 0.14% |
437,401
-598,500
| -58% | -$40.2M |
|
|
ITCI
127
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $31.9M | 0.14% |
521,443
+429,708
| +468% | +$22.3M |
|
|
ISEE
128
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $31.4M | 0.14% |
1,868,628
+8,811
| +0.5% | +$130K |
|
129
Adicet Bio
ACET
$75.1M
| $30.8M | 0.14% |
96,479
+1,024
| +1% | +$236K |
|
130
RLI Corp
RLI
$5.59B
| $30.4M | 0.14% |
550,000
| – | – |
|
131
Intercontinental Exchange
ICE
$87.7B
| $30M | 0.14% |
226,703
+73,180
| +48% | +$9.45M |
|
132
SS&C Technologies
SSNC
$18.9B
| $29.8M | 0.13% |
397,760
| – | – |
|
133
Analog Devices
ADI
$175B
| $29.4M | 0.13% |
177,972
-41,039
| -19% | -$6.65M |
|
134
Supernus Pharmaceuticals
SUPN
$2.37B
| $28.4M | 0.13% |
877,945
+250,000
| +40% | +$7.66M |
|
135
Bank of America
BAC
$413B
| $28.1M | 0.13% |
680,490
+67,101
| +11% | +$3.03M |
|
136
Toronto Dominion Bank
TD
$197B
| $28M | 0.13% |
315,708
+41,101
| +15% | +$3.31M |
|
137
Linde
LIN
$213B
| $27.7M | 0.13% |
75,606
+64,067
| +555% | +$19.8M |
|
138
Aflac
AFL
$58.7B
| $27.5M | 0.12% |
427,500
| – | – |
|
139
Surgery Partners
SGRY
$1.79B
| $27.3M | 0.12% |
495,695
+7,326
| +2% | +$362K |
|
140
Harmony Biosciences
HRMY
$2.4B
| $26.8M | 0.12% |
+550,000
| New | +$22.4M |
|
141
Biogen
BIIB
$31.9B
| $26.3M | 0.12% |
125,000
-25,000
| -17% | -$5.44M |
|
|
CERE
142
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $26.3M | 0.12% |
750,000
| – | – |
|
143
S&P Global
SPGI
$122B
| $26.2M | 0.12% |
63,768
+4,017
| +7% | +$1.64M |
|
|
XYZ
144
Block Inc
XYZ
$47.1B
| $25.7M | 0.12% |
189,385
+100,770
| +114% | +$12.2M |
|
145
Medtronic
MDT
$120B
| $25.5M | 0.11% |
229,588
+12,456
| +6% | +$1.32M |
|
146
MKS Inc
MKSI
$15.7B
| $24.9M | 0.11% |
166,250
+12,800
| +8% | +$1.99M |
|
147
PayPal
PYPL
$45.8B
| $24.9M | 0.11% |
+215,101
| New | +$28.6M |
|
148
DexCom
DXCM
$32.3B
| $24.5M | 0.11% |
191,180
+12,876
| +7% | +$1.41M |
|
149
Ryan Specialty Holdings
RYAN
$4.89B
| $24.2M | 0.11% |
624,000
+189,000
| +43% | +$7.18M |
|
150
LPL Financial
LPLA
$26.9B
| $23.7M | 0.11% |
129,858
| – | – |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q1 2022 Portfolio in Review
As of Q1 2022, Polar Capital Holdings held 509 positions worth $22.2B, down 17% from $26.7B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Polar Capital Holdings withdrew a net $713M in Q1 2022, closing 51 positions and reducing 123 holdings. Its most notable exit was PG&E Corporation, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Polar Capital Holdings opened a new position in Synopsys worth $89.3M.
- Polar Capital Holdings's largest Q1 2022 buy was Synopsys: 267,979 shares worth $89.3M.
- Polar Capital Holdings added most to Snap in Q1 2022, an estimated $92.3M increase.
- Polar Capital Holdings's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $180M.
- Polar Capital Holdings fully exited PG&E Corporation in Q1 2022, selling an estimated $116M.
- Polar Capital Holdings's ten largest holdings make up 44% of its $22.2B portfolio in Q1 2022.
- Polar Capital Holdings opened 64 new positions and closed 51 in Q1 2022.
- Polar Capital Holdings's portfolio value fell 17% quarter-over-quarter to $22.2B.
Based on Polar Capital Holdings's 13F filing for Q1 2022, filed 16 May 2022.